BENEVICH ERIC bought NBIX
April 15, 2024 · Form 4 insider transaction
BENEVICH ERIC bought 12,587 shares of Neurocrine Biosciences, Inc. at $81.05 per share, a transaction worth $1.02M. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
12,587
Price
$81.05
Total value
$1.02M
InsiderBENEVICH ERIC
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 15, 2024
Filing dateApril 17, 2024
Shares owned after53,365
OwnershipDirect
10b5-1 planNo
AmendedNo